{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:24Z","timestamp":1791994584984,"version":"4.4.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":153,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1111\/bjd.13717","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T16:08:09Z","timestamp":1427990889000},"page":"867-877","source":"Crossref","is-referenced-by-count":267,"title":["Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology"],"prefix":"10.1093","volume":"172","author":[{"given":"C.","family":"Feliciani","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of Parma; Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Joly","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Rouen, INSERM U 905; Rouen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Jonkman","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Medical Centre Groningen; Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zambruno","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cell Biology; Istituto Dermopatico dell'Immacolata, IRCCS; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zillikens","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of L\u00fcbeck; L\u00fcbeck Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ioannides","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Aristotle University of Thessaloniki; Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kowalewski","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Medical University of Warsaw; Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jedlickova","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Masaryk University; Brno Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Semmelweis University; Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Marinovic","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; University Hospital Center Zagreb; University of Zagreb School of Medicine; Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mimouni","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Tel-Aviv University; Tel-Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Akdeniz University; Antalya Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yayli","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Karadeniz Technical University; Trabzon Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hertl","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Philipps-University Marburg; Marburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Borradori","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospital of Bern - Inselspital, Freiburgstrasse 4; 3010 Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"key":"10.1111\/bjd.13717-BIB0001|bjd13717-cit-0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous pemphigoid: from the clinic to the bench","volume":"30","author":"Zenzo","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.13717-BIB0002|bjd13717-cit-0002","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/bjd.13717-BIB0003|bjd13717-cit-0003","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0004|bjd13717-cit-0004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13717-BIB0005|bjd13717-cit-0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0006|bjd13717-cit-0006","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a U.K. case-control study","volume":"149","author":"Lloyd-Lavery","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.13717-BIB0007|bjd13717-cit-0007","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"Della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0008|bjd13717-cit-0008","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13717-BIB0009|bjd13717-cit-0009","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.det.2011.03.001","article-title":"Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases","volume":"29","author":"Pohla-Gubo","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.13717-BIB0010|bjd13717-cit-0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13717-BIB0011|bjd13717-cit-0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","article-title":"The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid","volume":"118","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0012|bjd13717-cit-0012","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1523-1747.ep12338088","article-title":"A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13717-BIB0013|bjd13717-cit-0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1111\/bjd.13717-BIB0014|bjd13717-cit-0014","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13717-BIB0015|bjd13717-cit-0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1085-5629(96)80044-7","article-title":"Eosinophilic and neutrophilic spongiosis: clues to the diagnosis of immunobullous diseases and other inflammatory disorders","volume":"15","author":"Machado-Pinto","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/bjd.13717-BIB0016|bjd13717-cit-0016","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-5945-4-10","article-title":"Enhanced diagnostic immunofluorescence using biopsies transported in saline","volume":"4","author":"Vodegel","year":"2004","journal-title":"BMC Dermatol"},{"key":"10.1111\/bjd.13717-BIB0017|bjd13717-cit-0017","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.12308","article-title":"The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0018|bjd13717-cit-0018","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0190-9622(90)70094-X","article-title":"Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita","volume":"22","author":"Gammon","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13717-BIB0019|bjd13717-cit-0019","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaad.2008.06.022","article-title":"The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease","volume":"59","author":"Magro","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13717-BIB0020|bjd13717-cit-0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2230.2003.01419.x","article-title":"Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid","volume":"28","author":"Chan","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13717-BIB0021|bjd13717-cit-0021","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","article-title":"Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid","volume":"147","author":"Roussel","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0022|bjd13717-cit-0022","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/bjd.13717-BIB0023|bjd13717-cit-0023","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archderm.1996.03890260053008","article-title":"Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping","volume":"132","author":"Jong","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0024|bjd13717-cit-0024","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archderm.139.8.1007","article-title":"A practical technique for differentiation of subepidermal bullous diseases","volume":"139","author":"Wozniak","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0025|bjd13717-cit-0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/bjd.13717-BIB0026|bjd13717-cit-0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12477198","article-title":"Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectron microscopy","volume":"97","author":"B\u00e9dane","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13717-BIB0027|bjd13717-cit-0027","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0028|bjd13717-cit-0028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","article-title":"Mortality of bullous pemphigoid in Switzerland: a prospective study","volume":"165","author":"Cortes","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0029|bjd13717-cit-0029","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13717-BIB0030|bjd13717-cit-0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13717-BIB0031|bjd13717-cit-0031","first-page":"10","article-title":"Interventions for bullous pemphigoid","volume":"6","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13717-BIB0032|bjd13717-cit-0032","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.det.2011.06.003","article-title":"Evidence-based management of bullous pemphigoid","volume":"29","author":"Daniel","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.13717-BIB0033|bjd13717-cit-0033","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/0378-6323.82400","article-title":"Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: a systematic review","volume":"77","author":"Singh","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.13717-BIB0034|bjd13717-cit-0034","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(84)92565-0","article-title":"Plasma exchange in bullous pemphigoid","volume":"2","author":"Roujeau","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/bjd.13717-BIB0035|bjd13717-cit-0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0036|bjd13717-cit-0036","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1993.01680220061016","article-title":"Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid","volume":"129","author":"Guillaume","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0037|bjd13717-cit-0037","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0038|bjd13717-cit-0038","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archderm.144.7.946-a","article-title":"Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid","volume":"144","author":"Bystryn","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0039|bjd13717-cit-0039","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1365-2133.2011.10531.x","article-title":"Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study","volume":"165","author":"Du-Thanh","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0040|bjd13717-cit-0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0190-9622(96)80085-5","article-title":"Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases","volume":"34","author":"Bouscarat","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13717-BIB0041|bjd13717-cit-0041","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2133.2004.06241.x","article-title":"Chlorambucil as a steroid-sparing agent in bullous pemphigoid","volume":"151","author":"Chave","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0042|bjd13717-cit-0042","first-page":"309","article-title":"Cyclosporin in the treatment of bullous pemphigoid: preliminary study","volume":"113","author":"Barth\u00e9l\u00e9my","year":"1986","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.13717-BIB0043|bjd13717-cit-0043","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1684\/ejd.2012.1717","article-title":"High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid","volume":"22","author":"Gaitanis","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0044|bjd13717-cit-0044","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000339071","article-title":"Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption","volume":"224","author":"M\u00fcller","year":"2012","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13717-BIB0045|bjd13717-cit-0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1744-9987.2012.01075.x","article-title":"Immunoadsorption in dermatology","volume":"16","author":"Meyersburg","year":"2012","journal-title":"Ther Apher Dial"},{"key":"10.1111\/bjd.13717-BIB0046|bjd13717-cit-0046","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13717-BIB0047|bjd13717-cit-0047","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/jid.2013.236","article-title":"Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients","volume":"133","author":"Hall","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13717-BIB0048|bjd13717-cit-0048","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.13717-BIB0049|bjd13717-cit-0049","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/jdv.12155","article-title":"Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients","volume":"28","author":"Gual","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13717-BIB0050|bjd13717-cit-0050","first-page":"38","article-title":"Role of the nurse in care of bullous pemphigoid","volume":"160","author":"Roux-Villet","year":"2010","journal-title":"Rev Infirm"},{"key":"10.1111\/bjd.13717-BIB0051|bjd13717-cit-0051","unstructured":"BC Cancer Agency Immunization guidelines http:\/\/www.bccancer.bc.ca\/NR\/rdonlyres\/8B9A8033-61A8-4862-B113-96916C59C04C\/12801\/ImmunizationGuidelines.pdf"},{"key":"10.1111\/bjd.13717-BIB0052|bjd13717-cit-0052","unstructured":"Centers for Disease Control and Prevention Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00023141.htm"},{"key":"10.1111\/bjd.13717-BIB0053|bjd13717-cit-0053","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossmann","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/bjd.13717-BIB0054|bjd13717-cit-0054","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamadermatol.2013.5757","article-title":"Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study","volume":"150","author":"Fichel","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.13717-BIB0055|bjd13717-cit-0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13717-BIB0056|bjd13717-cit-0056","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.annder.2011.01.009","article-title":"Bullous pemphigoid Guidelines for the diagnosis and treatment. Centres de R\u00e9f\u00e9rence des Maladies Bulleuses Auto-immunes. Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie","volume":"138","author":"Bernard","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.13717-BIB0057|bjd13717-cit-0057","unstructured":"European Dermatology Forum SOP for creation of European Dermatology Guidelines http:\/\/www.turkderm.org.tr\/turkdermData\/Uploads\/files\/Guidelines%20_SOP.pdf"},{"key":"10.1111\/bjd.13717-BIB0058|bjd13717-cit-0058","unstructured":"AGREE Practice guidelines http:\/\/www.agreetrust.org\/resource-centre\/practice-guidelines\/"},{"key":"10.1111\/bjd.13717-BIB0059|bjd13717-cit-0059","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 Guide d'analyse de la litt\u00e9rature et gradation des recommandations http:\/\/www.has-sante.fr\/portail\/jcms\/c_434715\/fr\/guidedanalyze"},{"key":"10.1111\/bjd.13717-BIB0060|bjd13717-cit-0060","unstructured":"AWMF Guidelines: Klassifikation S2-Leitlinen http:\/\/www.awmf.org\/en\/clinical-practice-guidelines\/awmf-guidance\/cpg-development\/awmf-regelwerk-01-planung-und-organisation\/po-stufenklassifikation\/klassifikation-s2e-und-s2k.html"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13717","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13717\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:39:13Z","timestamp":1691541553000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/4\/867\/6616013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13717","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}